SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-066566
Filing Date
2023-08-14
Accepted
2023-08-14 09:15:23
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_virpaxpharma.htm   iXBRL 10-Q 534616
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR RULE f10q0623ex31-1_virpaxpharma.htm EX-31.1 10046
3 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR RULE f10q0623ex31-2_virpaxpharma.htm EX-31.2 10050
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN f10q0623ex32-1_virpaxpharma.htm EX-32.1 4135
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(B) OR RULE 15D- f10q0623ex32-2_virpaxpharma.htm EX-32.2 4211
  Complete submission text file 0001213900-23-066566.txt   2997709

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vrpx-20230630.xsd EX-101.SCH 32914
7 XBRL CALCULATION FILE vrpx-20230630_cal.xml EX-101.CAL 14532
8 XBRL DEFINITION FILE vrpx-20230630_def.xml EX-101.DEF 136607
9 XBRL LABEL FILE vrpx-20230630_lab.xml EX-101.LAB 296639
10 XBRL PRESENTATION FILE vrpx-20230630_pre.xml EX-101.PRE 152557
44 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_virpaxpharma_htm.xml XML 284879
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 231166715
SIC: 2834 Pharmaceutical Preparations